ICH GCP R3 is now in English & EU languages. Book Now
  • AI ClinicalAI ClinicalNewRight Arrow
  • Clinical PracticeClinical PracticeRight Arrow
  • PharmacovigilancePharmacovigilanceRight Arrow
  • ManufacturingManufacturingRight Arrow
  • Laboratory PracticeLaboratory PracticeRight Arrow
  • DistributionDistributionRight Arrow
  • Medical DevicesMedical DevicesRight Arrow

About

Cleaning Validation is a twelve-module programme that follows the cleaning process from contamination risk assessment through verified, validated, and continuously monitored state. The course covers the full Stage 1 / Stage 2 / Stage 3 lifecycle, soil characterisation, swab and rinse sampling, analytical methods (TOC, HPLC, conductivity), the three acceptance-criteria models (1/1000 dose, 10 ppm, PDE/HBEL), worst-case selection, validation protocols, and the audit perspective on cleaning programmes anchored in real recalls, FDA 483s, and EU GMP findings.

Cleaning Validation is recommended for validation engineers, QA managers, manufacturing operations leads, microbiologists, analytical chemists, and engineering staff in pharmaceutical, biotech, and medical-device facilities particularly multi-product sites. On completion, learners can scope cleaning validation programmes using risk-based principles, characterise soil and develop cleaning processes, select sampling and analytical methods to defensible standards, calculate acceptance limits using PDE/HBEL methodology, perform worst-case product and equipment grouping, build inspection-grade validation protocols and final reports, and present a defensible cleaning programme to inspectors from FDA, EMA, MHRA, and PIC/S.

Course Syllabus

  1. What Is Cleaning Validation?
  2. Why Cleaning Validation Matters
  3. The Three Stages of Cleaning Validation
  4. Three-Stage Cleaning Validation Lifecycle
  5. Critical Cleaning Validation Concepts
  6. Cross-Industry Relevance
  7. Stakeholders in Cleaning Validation
  8. Common Misconceptions
  9. Real-World Failure: The Carryover Recall
  10. Cleaning Validation Across Lifecycle
  11. Modern Trends in Cleaning Validation
  12. Cleaning Validation in the Quality System
  13. Connecting to Patient Safety

  1. The Regulatory Landscape
  2. FDA 21 CFR 211.67
  3. EU GMP Chapter 5 Production
  4. EU GMP Annex 15 Qualification and Validation
  5. EMA HBEL Guideline (2014)
  6. ICH Q7 — API GMP
  7. PIC/S Cleaning Validation Recommendation
  8. ASTM E3106 Standard Practice
  9. ICH Q9 Quality Risk Management
  10. ICH Q10 Pharmaceutical Quality System

  1. What Is Contamination?
  2. What Is Cross-Contamination?
  3. Sources of Contamination
  4. Cross-Contamination Pathways
  5. Types of Residues to Control
  6. High-Risk Product Categories
  7. Quantifying Cross-Contamination Risk
  8. Process Improvement: Programme Maturity
  9. Connecting to Cleaning Validation

  1. Why Lifecycle Thinking Matters
  2. Stage 1 Cleaning Process Design
  3. Lifecycle Phases with Quality Gates
  4. Stage 2 Cleaning Process Qualification
  5. Stage 3 Continued Process Verification
  6. Lifecycle Quality Gates
  7. Cleaning Validation Master Plan
  8. Equipment Cleaning Matrix
  9. Worst-Case Selection Methodology
  10. Validation Protocol Structure
  11. Process Improvement: Lifecycle Optimisation

  1. What Is Cleaning Process Development?
  2. Soil Characterisation
  3. Cleaning Agent Selection
  4. Cleaning Mechanisms
  5. Cleaning Parameters
  6. TACT Cleaning Parameters
  7. Equipment Cleanability Assessment
  8. Manual vs Automated Cleaning
  9. Clean-In-Place (CIP) Systems
  10. Manual Cleaning Best Practices
  11. Cleaning Validation Process Flow
  12. Process Improvement: Development Optimisation
  13. Connecting Development to Validation

  1. Why Sampling Matters
  2. Swab vs Rinse Sampling Comparison
  3. Sampling Approaches Overview
  4. Swab Sampling Technique
  5. Swab Sampling Limitations
  6. Rinse Sampling Technique
  7. Rinse Sampling Limitations
  8. Sampling Location Selection
  9. Recovery Studies
  10. Recovery Factor Considerations
  11. Visual Inspection
  12. Placebo Sampling
  13. Process Improvement: Sampling Programme
  14. Connecting Sampling to Acceptance Criteria

  1. Why Analytical Methods Matter
  2. Common Analytical Techniques
  3. HPLC for Specific Residues
  4. TOC for Non-Specific Monitoring
  5. Method Validation per ICH Q2(R2)
  6. Method Sensitivity Requirements
  7. Method Specificity and Interferences
  8. Method Transfer and Maintenance
  9. Process Improvement: Analytical Programme
  10. Connecting Analytical Methods to Validation

  1. Why Acceptance Criteria Matter
  2. The Three Acceptance Criteria Models
  3. Health-Based Exposure Limits
  4. Acceptance Criteria Approaches
  5. PDE Derivation Methodology
  6. Maximum Allowable Carryover (MACO)
  7. MACO Calculation Flow
  8. Surface Residue Limits
  9. Rinse Water Limits
  10. Cleaning Agent Residue Limits
  11. Microbial Acceptance Criteria
  12. Visual Cleanliness
  13. Process Improvement: Acceptance Criteria Programme
  14. Connecting Acceptance Criteria to Programme

  1. Why Risk-Based Approach Matters
  2. ICH Q9 Application
  3. Risk-Based Validation Effort
  4. Risk Assessment Tools
  5. Worst-Case Product Selection
  6. Worst-Case Equipment Location
  7. Product Grouping Strategies
  8. Equipment Grouping Strategies
  9. Risk-Based Sampling Plans
  10. Risk-Based Acceptance Criteria
  11. Risk-Based Continued Verification
  12. Process Improvement: Risk Programme
  13. Connecting Risk to Programme

  1. Why Documentation Matters
  2. Cleaning Validation Document Hierarchy
  3. Cleaning Validation Master Plan
  4. Validation Plan
  5. Validation Protocol Structure
  6. Equipment Cleaning Matrix
  7. Validation Summary Report
  8. Standard Operating Procedures
  9. Recovery Study Documentation
  10. Continued Verification Records
  11. Real Failure: The Backdated Records
  12. ALCOA+ Data Integrity Principles
  13. Real Failure: The Outdated SOP
  14. Real Failure: The Missing Cross-Reference
  15. Process Improvement: Documentation Quality
  16. Documentation Across Lifecycle
  17. Integration with Other Records

  1. Why Inspection Readiness Matters
  2. Types of Audits
  3. Self-Inspection Programme
  4. Audit Scope for Cleaning Validation
  5. Pre-Inspection Preparation
  6. Inspection Day Behaviour
  7. Documents Inspectors Request
  8. More Documents Inspectors Request
  9. Inspection Findings Severity
  10. Findings Classification
  11. Responding to Findings
  12. Inspection Response Workflow
  13. FDA Form 483
  14. FDA Warning Letter
  15. EU GMP Inspection Outcomes
  16. Process Improvement: Audit-Ready Operations
  17. Inspection Day Roles
  18. Cultural Indicators of Maturity

  1. Why Case Studies Matter
  2. Sources of Industry Learning
  3. Patterns in Cleaning Validation Failures
  4. Common Themes Across Failures
  5. What Mature Organisations Do Differently
  6. Building a Learning Organisation
  7. Cultural Indicators of Maturity
  8. Cultural Warning Signs
  9. How to Use Case Studies
  10. Process Improvement: Continuous Learning

Course Benefits

Benefits cpd_points icon
CPD Points

Gain Continuing Professional Development (CPD) Points, accredited by The Faculty of Pharmaceutical Medicine of the Royal College of Physicians of the United Kingdom. These can be used to count towards the distance learning element of any scheme that comes under the umbrella of The Academy of Medical Royal Colleges or any other scheme for which there is mutual recognition.

Benefits certification icon
Certification

Receive a personal certificate to show your subject knowledge on course completion.

Benefits affordable icon
Affordable

You get excellent value through our cost-effective prices. We can also offer you group discounts on larger purchases.

Benefits flexible icon
Flexibility

The course saves you time through the convenience of online availability. This lets you complete the interactive course at your own comfort.

Benefits up_to_date icon
Keep Up to Date

You will stay up to date with any changes to EU GMP Annex 15, FDA process validation guidance, EMA HBEL/PDE guideline, and ICH Q9 as our training courses are constantly monitored, reviewed and updated.

Benefits industry_experts icon
Learn from Industry Experts

The course content has been developed by industry practitioners and subject-matter experts to ensure that learners can apply the principles directly in their daily work. Every module follows a consistent rhythm — concept, regulatory context, real-world failure, audit perspective, preventive controls, and a knowledge check.


Our Certified Customers

novartis
NHS
takeda
roche
dhl

Learner Rating & Reviews

4.7
★★★★★★
Average Rating
536 global ratings
★★★★★
87.0%
★★★★★
5.0%
★★★★★
3.0%
★★★★★
3.0%
★★★★★
2.0%
RC

Working with Whitehall training for the last two years of partnership has been a very successful experience – I have fast access to all the GCP course...

SM

I have finalised the demo for the ICH-GCP E6 R3 refresher course. Overall, I liked the content and the interface. I also want to thank Whitehall Train...